Victory Capital Management Boosts Stake in Zimmer Biomet

Investment firm increases holdings in medical device company by nearly 25% in Q3

Published on Mar. 4, 2026

Got story updates? Submit your updates here. ›

Victory Capital Management Inc. raised its position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 24.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm now owns 1,924,763 shares of the medical equipment provider's stock, worth approximately $198.6 million.

Why it matters

Zimmer Biomet is a leading global medical device company focused on musculoskeletal healthcare. Victory Capital's increased stake suggests the investment firm sees strong potential in the company's future performance and growth prospects.

The details

Victory Capital Management acquired an additional 383,570 shares of Zimmer Biomet during the third quarter, bringing its total holdings to nearly 2 million shares. This represents about 0.97% of the company's outstanding stock. The move comes as Zimmer Biomet has faced some analyst downgrades and price target cuts in recent months amid broader market volatility.

  • Victory Capital Management filed its 13F report for the 3rd quarter of 2026 on March 4, 2026.

The players

Victory Capital Management Inc.

An American investment management firm that oversees over $150 billion in client assets.

Zimmer Biomet Holdings, Inc.

A global medical device company focused on musculoskeletal healthcare, headquartered in Warsaw, Indiana.

Got photos? Submit your photos here. ›

The takeaway

Victory Capital's increased stake in Zimmer Biomet suggests the investment firm sees long-term value in the medical device maker despite some recent analyst concerns. This vote of confidence could signal that Zimmer Biomet's fundamentals remain strong and the company is well-positioned for future growth.